Smart Insulin for Diabetes Treatment

A team of international scientists developed a new "smart insulin," named NNC2215, that responds in real-time to changes in blood glucose levels, marking a breakthrough in diabetes treatment. This insulin molecule remains inactive when blood sugar is low and activates as glucose levels rise, offering improved management for Type 1 and Type 2 diabetes patients. The smart insulin has been tested on rats and pigs, showing promising results, but it requires further refinement to ensure a gradual release. Human trials are expected, and the innovation could greatly enhance the quality of life for those relying on insulin therapy.